Lidds Ab

Locally injectable modified release formulation of 2-hydroxyflutamid for prostate cancer

placeHelsingborg, Skane County, Sweden calendar_todayFounded 2004 groups6 employees language liddspharma.com

Innovation

8 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 433 times.

YearFilings
20123
20136
20145
20155
20163
20171
20183
20193
20201
20211
20221
20231

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%
Coming soon